Ytterbium-176 is a critical material used in the production of radioisotopes for oncology treatments, including Novartis’ Pluvicto. - The ...

Privately-held German radiopharmaceutical company Isotope Technologies Munich (ITM) has announced the appointment of Celine ...

Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company with two programs in clinical-stage development, today announced the departure of Dr. Brendan ...

French biotech Transgene (EPA: TNG) has named Simone Steiner as its new chief technical officer, in a move aimed at advancing ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the appointment of Simone Steiner, PhD, as ...

In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround ...

Hiranjith will lead the company’s commercial operations and its expansion globally, with primary focus in the US ...

Ytterbium-176 is a critical material used in the production of radioisotopes for oncology treatments, including Novartis’ Pluvicto.

Market Logic Software is introducing a new era of user-friendly data democratization by adding structured data analysis capabilities to its AI-powered market intelligence and insights platform, ...

Spain ranks first in Europe for clinical trials and is attracting investment in life sciences, but faces intense competition ...

Showcase your company news with guaranteed exposure both in print and online Don't miss the 2025 Commercial Real Estate Developers Power Breakfast on April 1st, 2025… The Wichita Business ...